General Information of Disease (ID: DISIZ0VJ)

Disease Name Invasive pulmonary aspergillosis
Disease Class 1F20: Aspergillosis
Disease Hierarchy
DIS01GPL: Grass pollen hypersensitivity
DISIZ0VJ: Invasive pulmonary aspergillosis
ICD Code
ICD-11
ICD-11: 1F20.0
ICD-10
ICD-10: B44.0
Expand ICD-11
'1F20.0
Expand ICD-10
'B44.0
Disease Identifiers
MONDO ID
MONDO_0005657
MESH ID
D001228
UMLS CUI
C0004030
MedGen ID
13939
HPO ID
HP:0020103
Orphanet ID
1163
SNOMED CT ID
65553006

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 1 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
ASP2397 DMQ5FEC Phase 2 Small molecular drug [1]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 4 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
BACE1 TTJUNZF Strong Biomarker [2]
CD209 TTBXIM9 Strong Biomarker [3]
IDO2 TTALN9W Strong Genetic Variation [4]
TICAM1 TT2GQT6 Strong Biomarker [5]
------------------------------------------------------------------------------------
This Disease Is Related to 4 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
CLEC7A OTRTBH27 Limited Biomarker [6]
ICAM3 OTTZ5A5D Strong Biomarker [7]
PTX3 OTPXHRKU Strong Biomarker [8]
TRIM69 OTTEGTRD Strong Biomarker [5]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03327727) VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults. U.S. National Institutes of Health.
2 Functional selection of protease inhibitory antibodies.Proc Natl Acad Sci U S A. 2019 Aug 13;116(33):16314-16319. doi: 10.1073/pnas.1903330116. Epub 2019 Jul 30.
3 Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin mediates binding and internalization of Aspergillus fumigatus conidia by dendritic cells and macrophages.J Immunol. 2004 Nov 1;173(9):5635-43. doi: 10.4049/jimmunol.173.9.5635.
4 Genetic Polymorphisms Affecting IDO1 or IDO2 Activity Differently Associate With Aspergillosis in Humans.Front Immunol. 2019 May 7;10:890. doi: 10.3389/fimmu.2019.00890. eCollection 2019.
5 PTX3 binds MD-2 and promotes TRIF-dependent immune protection in aspergillosis.J Immunol. 2014 Sep 1;193(5):2340-8. doi: 10.4049/jimmunol.1400814. Epub 2014 Jul 21.
6 Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity.Blood. 2010 Dec 9;116(24):5394-402. doi: 10.1182/blood-2010-04-279307. Epub 2010 Aug 31.
7 Overexpression of Dendritic Cell-Specific Intercellular Adhesion Molecule-3-Grabbing Nonintegrin in Dendritic Cells Protecting against Aspergillosis.Chin Med J (Engl). 2018 Nov 5;131(21):2575-2582. doi: 10.4103/0366-6999.244103.
8 Pentraxin 3 in bronchoalveolar lavage fluid and plasma in non-neutropenic patients with pulmonary aspergillosis.Clin Microbiol Infect. 2019 Apr;25(4):504-510. doi: 10.1016/j.cmi.2018.06.015. Epub 2018 Jun 28.